Viatris Rolls Out 3 Follow-On AGs for Norvasc, Cardenalin, Relpax

March 8, 2021
Viatris Pharmaceuticals Japan said on March 5 that authorized generic (AG) versions are now available for the hypertension treatments Norvasc (amlodipine) and Cardenalin (doxazosin mesilate) and the migraine drug Relpax (eletriptan). Amlodipine Tablets/OD Tablets “Pfizer”, Doxazosin Tablets “Pfizer”, and Eletriptan...read more